カテゴリ： MarketLine, スイス, 企業調査

Pictet & Cie Group SCA：企業の戦略・SWOT・財務情報

◆英語タイトル：Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C1195
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：36
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：スイス
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Pictet & Cie Group SCA – Strategy, SWOT and Corporate Finance Report
Summary

Pictet & Cie Group SCA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Pictet & Cie Group SCA (PCG) offers wealth management, asset management, and asset services. Wealth Management offers customized discretionary and advisory investment solutions across all asset classes, and execution-only and family-office services. Asset management includes investment management services through mutual funds and segregated accounts. It manages fixed income, equity, alternatives and multi-asset strategies. Asset services include custody services, fund solutions, and trading services. Alternative investments comprise private equity, hedge funds, and real estate. It operates through a network of branch offices, relationship managers, and online portals and serves high and ultra-high net worth individuals, wealthy families, corporations, and individual clients. The company operates in Asia, Europe, the Middle East, and North America. PCG is headquartered in Geneva, Switzerland.

Scope

- Detailed information on Pictet & Cie Group SCA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Pictet & Cie Group SCA in the form of a SWOT analysis
- An in-depth view of the business model of Pictet & Cie Group SCA including a breakdown and examination of key business segments
- Intelligence on Pictet & Cie Group SCA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Pictet & Cie Group SCA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Pictet & Cie Group SCA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Pictet & Cie Group SCA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Pictet & Cie Group SCA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Banque Pictet & Cie SA: Company Overview 9
Banque Pictet & Cie SA: Overview and Key Facts 9
Banque Pictet & Cie SA: Overview 9
Banque Pictet & Cie SA: Key Facts 9
Banque Pictet & Cie SA: Key Employees 10
Banque Pictet & Cie SA: Major Products and Services 11
Banque Pictet & Cie SA: Company History 12
Banque Pictet & Cie SA: Management Statement 14
Banque Pictet & Cie SA: Key Competitors 16
Banque Pictet & Cie SA: Company Analysis 17
Banque Pictet & Cie SA: Business Description 17
Banque Pictet & Cie SA: SWOT Analysis 18
Banque Pictet & Cie SA: SWOT Overview 18
Pictet & Cie Group SCA: Strengths 18
Pictet & Cie Group SCA: Weaknesses 19
Pictet & Cie Group SCA: Opportunities 19
Pictet & Cie Group SCA: Threats 20
Banque Pictet & Cie SA: Corporate Financial Deals Activity 22
Banque Pictet & Cie SA: Financial Deals Overview 22
Banque Pictet & Cie SA: Targets and Partners 24
Banque Pictet & Cie SA: Top Deals 2014 – 2018YTD* 25
Banque Pictet & Cie SA: Mergers and Acquisitions 26
Banque Pictet & Cie SA: Divestments 27
Banque Pictet & Cie SA: Recent Developments 28
Banque Pictet & Cie SA: News and Events Summary 28
Banque Pictet & Cie SA: Business Expansion 30
Banque Pictet & Cie SA: Corporate Governance 32
Banque Pictet & Cie SA: Financial Performance 32
Banque Pictet & Cie SA: Strategy and Operations 33
Appendix 34
Contact Us 34
Methodology 34
About MarketLine 35

List of Tables
Table 1: Banque Pictet & Cie SA: Key Facts
Table 2: Banque Pictet & Cie SA: Key Employees
Table 3: Banque Pictet & Cie SA: Key Competitors
Table 4: Banque Pictet & Cie SA: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Banque Pictet & Cie SA: M&A Activity by Geography (TTM*)
Table 6: Banque Pictet & Cie SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Banque Pictet & Cie SA: M&A Average Deal Size - Value (US$m)
Table 8: Banque Pictet & Cie SA: Targets and Partners
Table 9: Banque Pictet & Cie SA: Top Deals 2014 - 2018YTD*
Table 10: Banque Pictet & Cie SA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: Banque Pictet & Cie SA: M&A Activity by Geography (2014 - YTD*2018)
Table 12: Banque Pictet & Cie SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 13: Banque Pictet & Cie SA: Divestments by Geography (2014 - YTD*2018)
Table 14: Banque Pictet & Cie SA: News and Events Summary
Table 15: Banque Pictet & Cie SA: Business Expansion
Table 16: Banque Pictet & Cie SA: Corporate Governance
Table 17: Banque Pictet & Cie SA: Financial Performance
Table 18: Banque Pictet & Cie SA: Strategy and Operations

List of Figures
Figure 1: Banque Pictet & Cie SA: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Banque Pictet & Cie SA: M&A Activity by Geography (TTM*)
Figure 3: Banque Pictet & Cie SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Banque Pictet & Cie SA: M&A Average Deal Size - Value (US$m)
Figure 5: Banque Pictet & Cie SA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Banque Pictet & Cie SA: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Banque Pictet & Cie SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 8: Banque Pictet & Cie SA: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Pictet & Cie Group SCA：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Raytheon Technologies Corp (RTX)：企業の財務・戦略的SWOT分析
    Raytheon Technologies Corp (RTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Innova Biosciences Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Innova Biosciences Ltd (Innova), a subsidiary of Sygnis AG is a provider of bioconjugation technologies and services. The company products include antibody labeling kits, antibody purification kits, affinity resins, gold nanoparticle kits, immunogen kits, rapid Ab labeling kits and others. I …
  • National Health Insurance Company – Daman PJSC：企業の戦略・SWOT・財務分析
    National Health Insurance Company – Daman PJSC - Strategy, SWOT and Corporate Finance Report Summary National Health Insurance Company – Daman PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • AB Science SA (AB)：製薬・医療：M&Aディール及び事業提携情報
    Summary AB Science SA (ABS) is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors. The company's lead compound Masitinib, is a orally administered tyrosine kinase inhibitor targeting mast cells and selected kinases, including c-Kit, PDGFR, …
  • Exmar NV (EXM)：石油・ガス：M&Aディール及び事業提携情報
    Summary Exmar NV (Exmar), a subsidiary of Compagnie Maritime Belge SA, is a shipping and energy supply chain solutions provider. The company operates through four segments liquefied natural gas (LNG), offshore, liquid petroleum gas (LPG) and services. Its LNG segment offers floating liquefaction, fl …
  • Straumann Holding AG (STMN)：企業の財務・戦略的SWOT分析
    Straumann Holding AG (STMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Duke Energy Corporation (DUK)：石油・ガス：M&Aディール及び事業提携情報
    Summary Duke Energy Corp (Duke Energy) is an integrated energy utility that undertakes the generation, transmission, distribution and sale of electricity; transportation and sale of natural gas; and provision of related energy services in the Southeast and Midwest regions of the US. It also procures …
  • Dakota Valley Electric Cooperative：企業の戦略的SWOT分析
    Dakota Valley Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Seminole Electric Cooperative, Inc.：企業の戦略的SWOT分析
    Seminole Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Nanomerics Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Nanomerics Ltd (Nanomerics) is a healthcare solution provider that develops drug delivery solutions for poorly water soluble drugs, nucleic acids and peptides. The company offers products such as METDoloron, METSporine, METAmphizon, METEnkalon, MET undisclosed, MET ocular undiscl, ocular und …
  • Southern Petrochemical Industries Corp Ltd (SPIC)：企業の財務・戦略的SWOT分析
    Summary Southern Petrochemical Industries Corp Ltd (SPIC) is a chemical company that manufactures fertilizers for agriculture. The company offers products such as chemical fertilizer, organic and water soluble fertilizers, plant growth regulators, micro nutrients, and industrial products. Its chemic …
  • Aecon Group Inc (ARE)：企業の財務・戦略的SWOT分析
    Aecon Group Inc (ARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Eurovia (SAS)：企業の戦略・SWOT・財務情報
    Eurovia (SAS) - Strategy, SWOT and Corporate Finance Report Summary Eurovia (SAS) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • NeoPharm Co Ltd：企業の戦略・SWOT・財務情報
    NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • MedImmune LLC-製薬・医療分野：企業M&A・提携分析
    Summary MedImmune LLC (MedImmune), a subsidiary of AstraZeneca Plc, is a biotechnology company. It focuses on the research, development, manufacture and marketing of small molecules and biologics to address some of the major medical needs. The company develops therapeutic proteins, monoclonal antibo …
  • Greensmith Energy Management Systems LLC：企業の戦略的SWOT分析
    Greensmith Energy Management Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Imperial College London-製薬・医療分野：企業M&A・提携分析
    Summary Imperial College London (Imperial) is a research university that offers educational services. The university provides undergraduate and postgraduate courses. It offers courses in the field of science and technology, agriculture, business, the humanities, and medicine. It conducts clinical tr …
  • Cooper-Standard Holdings Inc.：企業の戦略・SWOT・財務情報
    Cooper-Standard Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Cooper-Standard Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • BBX Capital Corporation：企業のM&A・事業提携・投資動向
    BBX Capital Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BBX Capital Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • A1M Pharma AB (A1M)-製薬・医療分野：企業M&A・提携分析
    Summary A1M Pharma AB (A1M Pharma) develops and commercializes drug candidate for the diagnosis and treatment of pre-eclampsia (pandemic poisoning) and acute renal injury. The company offers ROSgard based on A1M (alpha-1-microglobulin), an endogenous protein with properties that captures and elimina …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆